Literature DB >> 21686931

Amelanotic melanoma presenting with cervical lymphadenopathy.

Abhishek Karnwal1, Edward Hadjihannas, Ali Sherif, Simon Grumett, Sudha Karnwal, John Mathews.   

Abstract

We present a rare case of an amelanotic melanoma of unknown primary presenting with cervical lymphadenopathy. A 20-year-old man presented with large left sided neck lump, associated dysphagia and weight loss. Examination revealed a hard mass in the left posterior triangle of neck and sacral sensory loss. Fine needle aspiration cytology of the mass suggested a poorly differentiated carcinoma. Computed tomography showed a left sided, 8×13 cm cervical mass with liver, lung and bony metastases. Histological examination of the lymph nodal mass confirmed the diagnosis of a metastatic amelanotic melanoma. The patient was treated with glucocorticoids, radiation therapy for the sacral bony deposit, and chemotherapy. Despite an initial reduction of his target lesions, his condition subsequently deteriorated and he died 4 months after diagnosis.

Entities:  

Year:  2009        PMID: 21686931      PMCID: PMC3028389          DOI: 10.1136/bcr.06.2008.0101

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  MALIGNANT MELANOMA OF UNKNOWN PRIMARY ORIGIN.

Authors:  T DASGUPTA; L BOWDEN; J W BERG
Journal:  Surg Gynecol Obstet       Date:  1963-09

2.  Metastatic melanoma to lymph nodes in patients with unknown primary sites.

Authors:  Janice N Cormier; Yan Xing; Lei Feng; Xuelin Huang; Latunya Davidson; Jeffrey E Gershenwald; Jeffrey E Lee; Paul F Mansfield; Merrick I Ross
Journal:  Cancer       Date:  2006-05-01       Impact factor: 6.860

Review 3.  Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute.

Authors:  Kenneth A Katz; Eric Jonasch; F Stephen Hodi; Robert Soiffer; Kimberly Kwitkiwski; Arthur J Sober; Frank G Haluska
Journal:  Melanoma Res       Date:  2005-02       Impact factor: 3.599

4.  Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group.

Authors:  K K Anbari; L M Schuchter; L P Bucky; R Mick; M Synnestvedt; D Guerry; R Hamilton; A C Halpern
Journal:  Cancer       Date:  1997-05-01       Impact factor: 6.860

5.  Electron microscopy and L-dopa reaction in the evaluation of an unusual amelanotic malignant melanoma of the neck.

Authors:  C W Anderson; M H Stevens; F Moatamed
Journal:  Otolaryngol Head Neck Surg       Date:  1981 Jul-Aug       Impact factor: 3.497

6.  Lymph node metastases in the neck and parotid gland from an unknown primary melanoma.

Authors:  A J Balm; B B Kroon; F J Hilgers; A Jonk; W J Mooi
Journal:  Clin Otolaryngol Allied Sci       Date:  1994-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.